Snopes readers regularly ask whether supplement brands like Neurocept and Burn Peak are legit. Here's how you can tell yourself.

Many workout and diet supplements aren't strictly regulated, so often you don't know exactly what is inside the products.

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Around the time people turn 30, they typically start to ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger clinical trials. Lowering blood sugar and increasing fat burning – without ...

The name "Ozempic 2.0" has been floating around on various outlets and on social media, as a trending nickname for the next generation of weight loss drugs that are in the works for 2026. Both Eli ...

Ozempic, and the class of weight loss drugs it has come to embody, has left its imprint seemingly everywhere: On the lives of millions of patients who’ve lost unprecedented amounts of weight. On ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 diabetes. A recent trial showed the drug enabled people with both conditions to ...

A new weight loss pill has shown promise as a more convenient medication for adults with obesity and type 2 diabetes. The once-daily pill appears to be effective and safe for these patients, according ...

A Michigan lawmaker is taking action to keep weight loss products out of teens’ hands. State Representative Erin Byrnes, D-Dearborn, introduced a bill to give the Board of Pharmacy the power to create ...

A daily pill could soon be available as an alternative to Wegovy and Ozempic injections after a trial found it led to substantial weight loss and improved blood sugar levels in people with obesity and ...

A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth of their body weight over nearly 18 months, a study said Thursday. A new ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...